Journey Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.9M Buy
62,121
+59,546
+2,312% +$4.8M 0.37% 78
2026
Q1
$223K Sell
2,575
-250
-9% -$23.9K 0.02% 234
2025
Q4
$271K Sell
2,825
-404
-13% -$39.2K 0.02% 233
2025
Q3
$308K Sell
3,229
-2,109
-40% -$194K 0.02% 233
2025
Q2
$465K Sell
5,338
-949
-15% -$80.5K 0.04% 204
2025
Q1
$565K Sell
6,287
-680
-10% -$60.8K 0.05% 185
2024
Q4
$548K Hold
6,967
0.07% 148
2024
Q3
$548K Hold
6,967
0.07% 148
2024
Q2
$548K Sell
6,967
-93
-1% -$7.62K 0.07% 146
2024
Q1
$615K Buy
7,060
+3,422
+94% +$292K 0.08% 146
2023
Q4
$300K Buy
3,638
+100
+3% +$7.62K 0.04% 177
2023
Q3
$277K Buy
3,538
+840
+31% +$70.3K 0.04% 181
2023
Q2
$238K Hold
2,698
0.04% 208
2023
Q1
$218K Sell
2,698
-728
-21% -$59.3K 0.03% 223
2022
Q4
$266K Buy
3,426
+100
+3% +$8.11K 0.07% 194
2022
Q3
$269K Sell
3,326
-1,307
-28% -$117K 0.07% 196
2022
Q2
$431K Buy
4,633
+2,308
+99% +$234K 0.1% 169
2022
Q1
$258K Buy
+2,325
New +$246K 0.07% 195
2021
Q4
Sell
-2,016
Closed -$253K 209
2021
Q3
$253K Buy
2,016
+28
+1% +$3.62K 0.08% 174
2021
Q2
$247K Buy
1,988
+160
+9% +$20.1K 0.08% 184
2021
Q1
$216K Sell
1,828
-25
-1% -$2.93K 0.08% 183
2020
Q4
$217K Buy
+1,853
New +$204K 0.08% 168

Other funds holding MDT

Journey Advisory Group's MDT Position: Q2 2026 in Review

Journey Advisory Group increased its Medtronic (MDT) stake by 2,312% in Q2 2026, buying an estimated $4.8M and bringing the position to 62,121 shares worth $4.9M. The position accounts for 0.37% of the portfolio, ranked #78.

Journey Advisory Group first reported a position in MDT in Q4 2020 and has held it in 22 quarters since. 1,527 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Journey Advisory Group held 62,121 shares of Medtronic worth $4.9M as of Q2 2026.
  • Journey Advisory Group bought 59,546 Medtronic shares in Q2 2026, an estimated $4.8M.
  • Medtronic made up 0.37% of Journey Advisory Group's portfolio in Q2 2026, its #78 holding.
  • Journey Advisory Group first reported a position in Medtronic in Q4 2020 and has held it in 22 quarters since.
  • 1,527 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.